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http://dx.doi.org/10.1016/j.fjs.2013.Summary Primary sarcomas of the esophagus are rare. We report the case of a 43-year-old
man with a high-grade spindle cell (undifferentiated pleomorphic) sarcoma of the cervical
esophagus just below the esophageal inlet. A huge tumor initially measuring 10 cm in length
abutting the esophageal inlet was found. It was an intraluminal tumor with only a transverse
pedicle stalk connected to the esophageal mucosa and had only invaded the submucosal layer.
After six courses of neo-adjuvant chemotherapy (over 1 year), the patient underwent total lar-
yngectomy, esophagectomy, and three-field radical lymph node dissection. This patient was
disease-free at the most recent follow-up. Although there have been several case reports of
undifferentiated pleomorphic sarcoma of the alimentary tract, undifferentiated pleomorphic
sarcoma of the esophagus is extremely rare. The behavior of sarcomas of the esophagus and
treatments are discussed, and the literature is reviewed.
Copyright ª 2013, Taiwan Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.f Thoracic Surgery, Depart-
General Hospital, No. 160,
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01.0031. Introduction
Esophageal cancer is the sixth most common cancer in the
world, and is especially common among Asian populations.
Most esophageal cancers are carcinomas. Primary sarcomasciation. Published by Elsevier Taiwan LLC. All rights reserved.
Spindle cell sarcoma of the esophagus 57of the esophagus are rare. Sarcomas and carcinosarcomas
have been found to account for approximately 0.1e1.5% of
all esophageal tumors,1 and these comprised only 5% of all
gastrointestinal sarcomas.2 High-grade undifferentiated
pleomorphic sarcoma or so-called pleomorphic malignant
fibrous histiocytoma (MFH) in the esophagus is very rare.
We report the case of a 43-year-old man with a huge high-
grade undifferentiated pleomorphic spindle cell sarcoma of
the cervical esophagus abutting the esophageal inlet, who
had chemotherapy followed by total esophagectomy. Un-
like carcinoma, esophageal sarcoma has a favorable prog-
nosis with radical resection.3 In this article, we describe the
features of our case and review the literature.Figure 2 Endoscopic findings of esophagus: tumor with
irregular mucosa and ulceration 15 cm from the incisors.2. Case report
A 43-year-old man presented with odynophagia, progressive
swallowing difficulty, and weight loss of 4 kg in 3 months.
The patient had been smoking one pack of cigarettes per
day for more than two decades and had a peptic ulcer,
which had been under medical control for 5 years. Esoph-
agography disclosed a huge tumor with severe mucosal
destruction about 10 cm in length in the upper esophagus
(Fig. 1). Endoscopic examination of the esophagus showed a
huge tumor with irregular mucosa with ulceration 15 cm
from the incisors, and the endoscope could not pass
through this region (Fig. 2). Bronchoscopy demonstrated
external compression on the posterior wall in the upper toFigure 1 Esophagography: a huge tumor with severe mucosal
destruction about 10 cm in length in the upper esophagus.middle trachea with obvious narrowing of up to 50% of the
lumen. A computed tomography (CT) scan of the chest and
upper abdomen showed a huge mass in the upper third of
the esophagus with luminal widening (Fig. 3), but no direct
invasion of adjacent structures or regional lymphadenopa-
thy. No evidence of metastasis was found from the position
emission tomography (PET) and whole-body bone scans.
The tumor markers a-fetoprotein (AFP), squamous cell
carcinoma antigen (SCC), and carcinoembryonic antigen
(CEA) were all within normal limits. Histopathological ex-
amination via endoscopic biopsy showed high-grade pleo-
morphic spindle cell proliferation with an intersecting
fascicular growing pattern and increased mitotic activities.
These tumor cells showed no immunoreaction to AE1/AE3,
EMA, desmin, CD117, S100, or CD34. A high-grade pleo-
morphic sarcoma was diagnosed.
The patient first received neo-adjuvant chemotherapy
with the MAID [mesna (700 mg), doxorubicin (15 mg/m2),
ifosfamide (2.5 mg/m2), and dacarbazine (250 mg/m2)]
regimen. After completion of six courses of chemotherapy,
a CT scan of the chest demonstrated that the tumor had
mildly shrunk in size. Although smaller, it still caused
obvious symptoms such as odynophagia and dysphagia. In
this period, the patient could tolerate a liquid diet. His
body weight was within an acceptable range. The patient
underwent radical surgery 1 year after diagnosis. Right-
sided video-assisted minithoracotomy was carried out.
The operation consisted of total esophagectomy, cardiec-
tomy, and total laryngectomy with three-field radical
lymph node dissection. Reconstruction was performed using
a gastric tube transposed to the neck via the posterior
mediastinal route. Pylomyotomy and feeding jejunostomy
were also performed. During the operation, one huge tumor
was noted in the upper esophagus just below the esopha-
geal inlet. Enlarged lymph nodes were found in the para-
esophgeal and parapancreatic areas.
Figure 3 Computed tomography of the chest and upper
abdomen: mass at the upper third of the esophagus with total
occlusion of the esophagus.
Figure 5 High-grade pleomorphic spindle cell proliferation
with intersecting fascicular growing pattern and increased
mitotic activities. Hemotoxylin and eosin stain, 200.
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tumor with only a thin transverse pedicle stalk 3 cm in
length connecting it to the esophageal mucosa. The gross
size of the tumor was 7  5  3 cm. It was located near the
esophageal inlet (Fig. 4) and had a firm and highly vascular
nature. The tumor had only invaded the submucosal layer,
and there were adequate peripheral margins of uninvolved
tissue in all planes. The second histopathological exami-
nation revealed the same tumor morphology as that of the
initial examination, and no lymph node metastasis was
found (Fig. 5). Immunohistochemical staining was AE1/AE3
(e), EMA (e), desmin (e), CD34 (e), CD-117 (e), S-100
(focal þ), CD68 (focal þ), CD163 (focal þ), CD35 (e), andFigure 4 Huge polypoid tumor, 7  5  3 cm in size, in the
upper third of the esophagus, abutting the opening and with a
firm and highly vascular nature.actin-M851 (focal þ). The immunohistochemical staining
showed complete absence of reactions with any lineage-
selective markers. The diagnosis of high-grade undifferen-
tiated pleomorphic sarcoma was confirmed.
The postoperative course was uneventful, and the pa-
tient was discharged in a stable condition. One year after
the operation, a CT scan of the chest and an upper
gastrointestinal endoscopy showed no tumor recurrence or
distant metastasis.3. Discussion
Primary sarcomas of the esophagus are rare neoplasms. In a
previous study, sarcomas and carcinosarcomas accounted
for approximately 0.1e1.5% of all esophageal tumors and
comprised only 5% of all gastrointestinal sarcomas.1,2
Leiomyosarcoma is the most common cell type of the
esophageal sarcomas. The rarity of esophageal sarcoma is
illustrated by the small number of previous reports, con-
sisting of single or small groups of patients. The clinical
symptoms of esophageal sarcomas are nonspecific and
different from those of esophageal carcinoma, and include
progressive dysphagia, loss of weight, regurgitation, retro-
sternal pain, respiratory distress, odynophagia, sensation of
a lump in the throat, hemorrhage, anemia, sudden death
(due to asphyxia), vomiting (food or tumor fragments),
fever, and cough. Our patient presented with odynophagia
and dysphagia initially, which was consistent with symp-
toms in previously reported cases.
Esophageal leiomyosarcoma is classified as polypoid in
60% of cases and infiltrative in 40%.4,5 Yamashita et al
reviewed seven cases of malignant fibrous histiocytoma in
the esophagus; all the cases involved pedunculated or
polypoid tumors.6 Those reports suggested that esophageal
sarcomas usually present as a polypoid mass. Esophagog-
raphy is a useful tool for evaluating the morphology of
esophageal tumors. Endoscopic examination is useful for
assessing the characteristics of the tumor and biopsy can be
helpful in differentiating sarcomas from carcinoma.
Table 1 Review of eight cases in men with primary undifferentiated pleomorphic sarcoma in the esophagus, including our case.
Reference Patient
age (y)
Symptoms Location Appearance Size
(cm)
Surgical procedure Outcome
Our case 43 Odynophagia,
dysphagia
Ce-Tu Polypoid tumor 7 Total esophagectomy Disease free
for 4 mo
Yamashita et al6 50 Dysphagia,
cough
Ce Dome-shaped tumor 12 Total esophagectomy Death within
7 mo
Naganuma et al9 78 Dysphagia Tm Polypoid tumor 7 Total esophagectomy Alive within
1 y
Sa´pi et al10 65 Dysphagia Tm Pedicled polypoid
tumor
3.3 Polypectomy Alive within
3 mo
Aagaard et al11 67 Dysphagia Tl Exophytic tumor 12 Esophagogastrectomy Death within
1 mo
Geboes et al12 59 Dysphagia Tm Pedunculated
exophytic tumor
9 Subtotal esophagotomy Unknown
Geboes et al12 57 Dysphagia Tm Pedunculated tumor 6 Esophagotomy Alive within
1 y
Takada et al13 46 Dysphagia,
hoarseness
Tm-Tl Pedunculated tumor 14 Subtotal esophagotomy Unknown
CeZ cervical part of esophagus; TlZ lower thoracic part of esophagus; TmZ middle thoracic part of esophagus; TuZ upper thoracic
part of esophagus.
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result, due to the esophageal mucosa overlying the
tumor. In our case, we could not completely evaluate the
morphology of the tumor by endoscopic examination or
esophagography on account of the huge size of tumor, so
we were unaware that it was a polypoid lesion until surgical
resection.
In our case, the diagnosis of high-grade undifferentiated
pleomorphic sarcoma was made through histopathological
examination, which revealed a pleomorphic spindle cell
appearance and no definitive reaction to immunohisto-
chemical staining. Undifferentiated high-grade pleomor-
phic sarcoma and so-called pleomorphic MFH are a group of
pleomorphic sarcomas that do not demonstrate a definitive
line of differentiation, even with immunohistochemistry.
The pathological diagnosis of undifferentiated high-grade
pleomorphic sarcoma is therefore one of exclusion, which is
made in the absence of reaction with any lineage-selective
markers in a high-grade pleomorphic sarcoma. Many un-
differentiated spindle cell sarcomas were previously clas-
sified as MFH. However, with current advances in diagnostic
techniques, it is expected that the number of tumors
diagnosed as MFH will decrease. Although MFH is common in
the extremities and retroperitoneal tissue, it is extremely
rare in the esophagus with only a few cases documented so
far.
Unlike carcinoma, esophageal sarcoma has a favorable
prognosis following radical resection. DeMeester et al3 re-
ported five cases of polypoid esophageal sarcoma. In their
study, in spite of the large size (mean size 7.1 cm) of the
tumors, they remained superficial within the esophageal
wall, and nodal or distant organ metastasis was absent in
four of the five patients. Rocco et al7 reviewed 17 cases of
esophageal leiomyosarcomas and curative resection was
carried out in 11 patients. The results showed that curative
resection offered a significant survival benefit to the pa-
tients and the authors suggested that esophagectomyshould be the standard management for most patients with
esophageal leiomyosarcoma. We reviewed previous reports
of undifferentiated pleomorphic sarcoma, and the eight
cases, including ours, are summarized in Table 1.6,9e13
In our case, although the cell type was uncommon (high-
grade undifferentiated pleomorphic sarcoma), the clinical
presentation was similar to that in previous reports.
Although the tumor was huge, it remained superficial within
the esophageal wall. However, in our case, the pre-
operative images and endoscopic findings failed to
confirm the degree of invasion of tumor completely; they
showed only that the tumor was just at the opening of the
esophagus. The total esophagectomy and total laryngec-
tomy were performed to ensure adequate radical resec-
tion. After surgical resection, the patient remained
disease-free at the most recent follow-up (1 year after
surgery). The characteristics of intraluminal polypoid
growth appear to allow endoscopic resection in certain
selected patients. In some early cancer lesions which are
small in size and with an obvious stalk, endoscopic poly-
poidectomy may be feasible.
Numerous modes of treatment, including surgical
resection, radiation, and chemotherapy have been used
either alone or in combination in limited cases. Chemo-
therapy does not appear to show any benefit in the treat-
ment of esophageal sarcomas. In our case, the initial
planned treatment was neo-adjuvant therapy for down-
staging. But the neo-adjuvant chemotherapy with the MAID
regimen only resulted in a partial response with an initial
slight reduction in tumor size. Lokesh et al8 reported a case
of spindle cell sarcoma of the esophagus in a 55-year-old
woman managed with radical radiotherapy alone. However,
the evidence for successful radiotherapy in esophageal
sarcomas is limited and its role in treatment strategies for
such lesions has not been well established.
In summary, we report a rare case of spindle cell sar-
coma of the esophagus. Our experience and previous
60 C.-J. Yang et al.evidence suggest that surgical resection can now be carried
out with low morbidity and mortality. Once the diagnosis
has been established, complete resection of esophageal
sarcomas may be performed to achieve optimal benefit.
Further studies are required to establish the potential roles
of chemotherapy and radiotherapy for spindle cell sarcoma
of the esophagus.References
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